Growth hormone treatment in growth retarded children with end stage renal failure: Effect on free/dissociable IGH-I levels

Journal of Pediatric Endocrinology and Metabolism

Volumn 10, Issue 2, 1997, Pages 197-202

  Bereket, Abdullah ^a   Lang, Charles H ^a   Blethen, Sandra L ^a   Kaskel, Frederick J ^a   Stewart, Charles ^a   Wilson, Thomas A ^a,b  

^a STONY BROOK UNIVERSITY MEDICAL CENTER   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

chronic renal failure; free IGF I; growth hormone; IGF I; insulin like growth factor I; uremia

Indexed keywords

HUMAN GROWTH HORMONE; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C;

ADOLESCENT; ARTICLE; BODY HEIGHT; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GROWTH RETARDATION; HUMAN; KIDNEY FAILURE; MALE; UREMIA;

BODY HEIGHT; BODY MASS INDEX; CHILD; FEMALE; GROWTH DISORDERS; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; KIDNEY FAILURE, CHRONIC; MALE;

EID: 0030989990     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Tönshoff B, Fine RN. Growth and growth hormone treatment in children with chronic renal insufficiency. In: Nissenson AR, Fine RN, Gentile DE, eds. Clinical Dialysis. East Norwalk: Appleton & Lange, 1995; 549-573.
2. Tönshoff B, Veldhuis JD, Heinrich U, Mehls O. Deconvolution analysis of spontaneous nocturnal growth hormone secretion in prepubertal children with chronic renal failure. Pediatr Res 1995; 37: 86-93.
3. Powell D, Rosenfeld R, Sperry J, Baker B, Hintz R. Serum concentration of insulin-like growth factor (IGF)-1, 1GF-2 and unsaturated somatomedin carrier proteins in children with chronic renal failure. Am J Kidney Dis 1987; 10: 287-292.
4. Phillips LS, Kopple JD. Circulating somatomedin activity and sulphate levels in adults with normal and impaired kidney function. Metabolism 1981; 30: 1091-1095.
5. Tönshoff B, Mehls O, Heinrich U, Blum WF, Ranke MB, Schauer A. Growth stimulating effects of recombinant human growth hormone in children with endstage renal disease. J Pediatr 1990; 116: 561-566.
6. Blum WF, Ranke MB, Kietzmann K, Tönshoff B, Mehls O. Growth hormone resistance and inhibition of somatomedin activity by excess of insulin-like growth factor binding protein in uraemia. Pediatr Nephrol 1991; 5: 539-544.
7. Liu F, Powell DR, Hintz RL. Characterization of insulin-like growth factor binding proteins in human serum from patients with chronic renal failure. J Clin Endocrinol Metab 1990; 70: 620-628.
8. Blum WF. Insulin-like growth factors (IGFs) and IGF binding proteins in chronic renal failure: Evidence for reduced secretion of IGFs. Acta Paediatr Scand 1991; 379 (Suppl): 24-31.
9. Tönshoff B, Blum WF, Wingen AM, Mehls O and the European Study Group for Nutritional Treatment of Chronic Renal Failure in Childhood. Serum insulin-like growth factors (IGFs) and IGF binding proteins 1, 2, and 3 in children with chronic renal failure: Relationship to height and glomerular filtration rate. J Clin Endocrinol Metab 1995; 80: 2684-2691.
10. Hammer LD, Kraemer HC, Wilson DM, Ritter PL, Dornbusch SM. Standardized percentile curves of body-mass index for children and adolescents. Am J Dis Child 1991; 145 :259-263.
11. Hamill PVV, Drisd TA, Johnson CL, Reed RB, Roche AF. Physical growth: National Center for Health Statistics percentiles. Am J Clin Nutr 1979; 32: 607-629.
12. Greulich WW, Pyle SI. Radiographic Atlas of Skeletal Development of the Hand and Wrist. Stanford: Stanford University Press, 1984.
13. Lee PDK, Powell D, Baker B, Liu F, Mathew G, Levitsky I, Gutierrez OD, Hintz RL. Characterization of a direct, non-extraction immunoradiometric assay for free IGF-I [Abstract]. Proceedings of the 76th Endocrine Society Meeting, Anaheim, CA, 1994; Abstract # 939.
14. Bereket A, Lang CH, Blethen SL, Gelato MC, Fan J, Frost RC, Wilson TA. Effect of insulin on the IGF System in children with new onset insulin dependent diabetes mellitus. J Clin Endocrinol Metab 1995; 80: 1312-1317.
15. Frystyk J, Skjaerbaek C, Dinesen B, Ørskov H. Free insulin-like growth factors (IGF-I and IGF-II) in human serum. FEBS Lett. 1991; 348: 185-191.
16. Bereket A, Wilson TA, Blethen SL, Fan J, Lang CH. Effect of acute nutritional state on circulating free IGF-I levels. Proceedings of the 10th International Congress of Endocrinology, San Fransisco 1996 Abstr # PI-506.
17. Jones JI, Clemmons DR. Insulin-like growth factors and their binding-proteins: Biological actions. Endocr Rev 1995; 16: 3-34.
18. Binoux M, Lalou C, Lasarre C, Blat C, Hossenlopp P. Limited proteolysis of insulin-like growth factor binding protein-3 (IGFBP-3): A physiological mechanism in the regulation of IGF bioavailability. In: Current Directions in Insulin-like Growth Factor Research. Le Roith D, Raizada MK, eds. New York: Plenum Press, 1994; 293-300.
19. Zapf J, Hauri C, Waldvogel M, Froesch ER. Acute metabolic effects and half-lives of intravenously administered insulin-like growth factors I and II in normal and hypophysectomized rats. J Clin Invest 1986; 77: 1768-1775.
20. Guler HP, Zapf J, Froesch ER. Short term metabolic effects of recombinant human insulin-like growth factor-I in healthy adults. New Engl J Med 1987; 317: 137-140.
21. Hizuka N, Takano K, Asakawa K, et al. Measurement of free form of insulin-like growth factor I in human plasma. Growth Regul 1991; 1: 51-55.
22. Lewitt MS, Saunders H, Baxter RC. Bioavailability of insulin-like growth factors (IGFs) in rats determined by the molecular distribution of human IGF-binding protein-3. Endocrinology 1993; 133: 1797-1802.
23. Binoux M, Roghani R, Hossenlopp P, Hardouin S, Gourmelen M. Molecular forms of human IGF binding proteins: Physiological implications. Acta Endocrinol 1991; 124: 41-47.
24. Fine RN, Koch VH, Boechat MI, et al. Recombinant human growth hormone (rhGH) treatment of children undergoing peritoneal dialysis. Pent Dial Int 1990; 10: 209-214.
25. Tönshoff B, Dietz,M, Haffner D, Tönshoff C, Stover B, Mehls O. Effects of two years growth hormone treatment in short children with renal disease. Acta Paediatr Scand 1991; 379 (Suppl): 33-41.